Related Experiment Video
Updated: Nov 30, 2025

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Merkel Cell Polyomavirus and Human Merkel Cell Carcinoma
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Abstract:
Merkel cell polyomavirus (MCPyV) is the most recently discovered human oncogenic virus. MCPyV asymptomatically infects most of the human population. In the elderly and immunocompromised, however, it can cause a highly lethal form of human skin cancer called Merkel cell carcinoma (MCC). Distinct from the productive MCPyV infection that replicates the viral genome as episomes, MCC tumors contain replication-incompetent, integrated viral genomes. Mutant MCPyV tumor antigen genes expressed from the integrated viral genomes are essential for driving the oncogenic development of MCPyV-associated MCC. In this chapter, we summarize recent discoveries on MCPyV virology, mechanisms of MCPyV-mediated oncogenesis, and the current therapeutic strategies for MCPyV-associated MCCs.
Insights
Merkel cell polyomavirus (MCPyV) causes lethal Merkel cell carcinoma (MCC) in immunocompromised individuals. MCC tumors feature integrated MCPyV genomes driving cancer development, with ongoing research into viral oncogenesis and therapies.
Area of Science:
- Virology
- Oncology
- Dermatology
Background:
- Merkel cell polyomavirus (MCPyV) is a recently identified human oncogenic virus.
- While asymptomatically infecting most people, MCPyV can cause Merkel cell carcinoma (MCC), a lethal skin cancer, in the elderly and immunocompromised.
- MCC tumors are characterized by integrated, replication-incompetent MCPyV genomes, unlike productive infections with episomal viral DNA.
Purpose of the Study:
- To summarize recent advancements in MCPyV virology.
- To elucidate the mechanisms of MCPyV-mediated oncogenesis in Merkel cell carcinoma.
- To review current therapeutic strategies for MCPyV-associated MCC.
Main Methods:
- Review of recent scientific literature on MCPyV.
- Analysis of viral genome integration and expression in MCC tumors.
- Synthesis of data on oncogenic pathways driven by MCPyV tumor antigens.
Main Results:
- MCPyV is the primary cause of MCC in most cases.
- Integrated MCPyV genomes and their mutated tumor antigens are crucial for MCC development.
- Understanding MCPyV's role in oncogenesis is key to developing targeted therapies.
Conclusions:
- MCPyV plays a critical role in the pathogenesis of Merkel cell carcinoma.
- Targeting MCPyV-specific mechanisms offers potential therapeutic avenues for MCC.
- Further research into MCPyV virology and oncogenesis is essential for improving patient outcomes.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

